UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000013122
Receipt number R000014068
Scientific Title A randomized phase II study of the efficacy and safety of combination of Bevacizumab/Pemetrexed versus Pemetrexed maintenance therapy in First-Line treatment of elderly patients with advanced or recurrent post-operative non-squamous and non-small cell lung cancer who received Bevacizumab / Pemetrexed induction therapy.
Date of disclosure of the study information 2014/02/10
Last modified on 2015/05/28 16:54:47

No. Disposal Last modified on Item of update
1 Insert 2014/02/10 16:33:02
2 Update 2015/01/22 13:30:56 Recruitment status
3 Update 2015/05/28 16:54:47 Institutions